Biphasic skin reactions during telaprevir-based therapy of Japanese patients infected with hepatitis C virus

被引：2
|
作者：
Kishi, Akiko [1 ]
Hayashi, Nobukazu [1 ]
Ohara, Kuniaki [1 ]
Aoki, Keiji [3 ]
Yamada, Ichimaro [3 ]
Ikeda, Kenji [2 ]
Kumada, Hiromitsu [2 ]
机构：
[1] Toranomon Gen Hosp, Dept Dermatol, Tokyo 1058470, Japan
[2] Toranomon Gen Hosp, Dept Hepatol, Tokyo 1058470, Japan
[3] Mitsubishi Tanabe Pharma Corp, Dev Div, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2014年 / 70卷 / 03期
关键词：
D O I：
10.1016/j.jaad.2013.11.003
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：584 / 586
页数：4
相关论文
共 50 条
  • [41] Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy
    Ogawa, Eiichi
    Furusyo, Norihiro
    Nakamuta, Makoto
    Kajiwara, Eiji
    Nomura, Hideyuki
    Dohmen, Kazufumi
    Takahashi, Kazuhiro
    Satoh, Takeaki
    Azuma, Koichi
    Kawano, Akira
    Tanabe, Yuichi
    Kotoh, Kazuhiro
    Shimoda, Shinji
    Hayashi, Jun
    JOURNAL OF HEPATOLOGY, 2013, 59 (04) : 667 - 674
  • [42] Dynamic and rapid changes in viral quasispecies by UDPS in chronic hepatitis C patients receiving telaprevir-based therapy
    Trimoulet, Pascale
    Pinson, Patricia
    Papuchon, Jennifer
    Foucher, Juliette
    Vergniol, Julien
    Chermak, Faiza
    Wittkop, Linda
    Castaing, Nadege
    Merrouche, Wassil
    Reigadas, Sandrine
    Molimard, Mathieu
    Kann, Michael
    Fleury, Herve
    de Ledinghen, Victor
    ANTIVIRAL THERAPY, 2013, 18 (05) : 723 - 727
  • [43] Telaprevir-based Triple Therapy for Retreatment of Chronic Hepatitis C Patients with Genotype Four Followed in Our Clinic
    Bestepe Dursun, Zehra
    Celik, Ilhami
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2016, 22 (02): : 58 - 61
  • [44] Second-Phase Hepatitis C Virus RNA Decline During Telaprevir-Based Therapy Increases With Drug Effectiveness: Implications for Treatment Duration
    Guedj, Jeremie
    Perelson, Alan S.
    HEPATOLOGY, 2011, 53 (06) : 1801 - 1808
  • [45] Re-treatment of hepatitis C virus genotype 1 infected patients with telaprevir-based triple therapy after telaprevir exposure in Phase 1 studies: deep sequencing analysis for persistence of resistant variants
    Susser, S.
    Flinders, M.
    Reesink, H. W.
    Zeuzem, S.
    Lawyer, G.
    Ghys, A.
    Van Eygen, V.
    Witek, J.
    De Meyer, S.
    Sarrazin, C.
    ANTIVIRAL THERAPY, 2014, 19 : A107 - A107
  • [46] Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis
    Ogawa, Eiichi
    Furusyo, Norihiro
    Nakamuta, Makoto
    Kajiwara, Eiji
    Nomura, Hideyuki
    Dohmen, Kazufumi
    Takahashi, Kazuhiro
    Satoh, Takeaki
    Azuma, Koichi
    Kawano, Akira
    Tanabe, Yuichi
    Kotoh, Kazuhiro
    Shimoda, Shinji
    Akahoshi, Tomohiko
    Maehara, Yoshihiko
    Hayashi, Jun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (09) : 1728 - 1735
  • [47] Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients
    Butt, Adeel A.
    Kanwal, Fasiha
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (01) : 96 - 104
  • [48] Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice
    Cento, Valeria
    Tontodonati, Monica
    Di Maio, Velia Chiara
    Bellocchi, Maria Concetta
    Valenti, Fabrizio
    Manunta, Alessandra
    Fortuna, Serena
    Armenia, Daniele
    Carioti, Luca
    Antonucci, Francesco Paolo
    Bertoli, Ada
    Trave, Francesca
    Cacciatore, Pierluigi
    Angelico, Mario
    Navarra, Pierluigi
    Neumann, Avidan U.
    Vecchiet, Jacopo
    Parruti, Giustino
    Babudieri, Sergio
    Perno, Carlo Federico
    Ceccherini-Silberstein, Francesca
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (03) : 233 - 241
  • [49] Efficacy of telaprevir-based therapy for difficult-to-treat patients with genotype 2 chronic hepatitis C in Japan
    Kumada, Hiromitsu
    Sato, Ken
    Takehara, Tetsuo
    Nakamuta, Makoto
    Ishigami, Masatoshi
    Chayama, Kazuaki
    Toyota, Joji
    Suzuki, Fumitaka
    Nakayasu, Yoshiyuki
    Ochi, Miyoko
    Yamada, Ichimaro
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2015, 45 (07) : 745 - 754
  • [50] Safety and Efficacy of Partial Splenic Embolization in Telaprevir-based Triple Therapy for Chronic Hepatitis C
    Kondo, Chisa
    Atsukawa, Masanori
    Tsubota, Akihito
    Shimada, Noritomo
    Abe, Hiroshi
    Itokawa, Norio
    Nakagawa, Ai
    Fukuda, Takeshi
    Matsushita, Yoko
    Nakatsuka, Katsuhisa
    Kawamoto, Chiaki
    Iwakiri, Katsuhiko
    Aizawa, Yoshio
    Sakamoto, Choitsu
    INTERNAL MEDICINE, 2015, 54 (02) : 119 - 126
12345